← Evidence map

ReviewAsian journal of andrology2012

Cyr61 is a potential prognostic marker for prostate cancer.

Naoki Terada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 22343491